Woodline Partners’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$693K Sell
1,434
-20,416
-93% -$5.42M ﹤0.01% 950
2026
Q1
$2.39M Buy
21,850
+19,656
+896% +$2.8M 0.01% 784
2025
Q4
$365K Buy
+2,194
New +$367K ﹤0.01% 936
2024
Q4
Sell
-69,396
Closed -$3.64M 1014
2024
Q3
$3.64M Buy
69,396
+2,934
+4% +$138K 0.03% 429
2024
Q2
$4.02M Buy
66,462
+1,517
+2% +$105K 0.04% 362
2024
Q1
$4.82M Buy
+64,945
New +$4.81M 0.04% 365

Other funds holding ALAB

Woodline Partners's ALAB Position: Q2 2026 in Review

Woodline Partners reduced its Astera Labs (ALAB) stake by 93% in Q2 2026, selling an estimated $5.42M and leaving 1,434 shares worth $693K. The position accounts for ﹤0.01% of the portfolio, ranked #950.

Woodline Partners first reported a position in ALAB in Q1 2024 and has held it in 6 quarters since. The position peaked at $4.82M in Q1 2024. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Woodline Partners held 1,434 shares of Astera Labs worth $693K as of Q2 2026.
  • Woodline Partners sold 20,416 Astera Labs shares in Q2 2026, an estimated $5.42M.
  • Astera Labs made up ﹤0.01% of Woodline Partners's portfolio in Q2 2026, its #950 holding.
  • Woodline Partners first reported a position in Astera Labs in Q1 2024 and has held it in 6 quarters since.
  • Woodline Partners's Astera Labs position peaked at $4.82M in Q1 2024.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.